dulaglutide

Home
Ligands
dulaglutide

GtoPdb Ligand ID: 7638

Synonyms: GLP-1Fc | LY2189265 | Trulicity®

dulaglutide is an approved drug (EMA & FDA (2014))

Comment: Dulaglutide is a GLP-1 mimetic. This treatment has the benefit of being long-acting, with in vivo studies showing peptide immunoreactivity is detactable >6 days following administration [2]. Therefore dulaglutide requires administration only once a week [1].

Summary
Biological activity
Clinical data
References
Structure
Similar ligands

No information available.

No information available.

Summary of Clinical Use
Dulaglutide is approved to improve blood sugar levels adults with type 2 diabetes, in conjunction with diet and excercise.

Summary of Clinical Use

Dulaglutide is approved to improve blood sugar levels adults with type 2 diabetes, in conjunction with diet and excercise.

Mechanism Of Action and Pharmacodynamic Effects
This synthetic peptide mimics the action of GLP-1 at the GLP-1 receptor.

Mechanism Of Action and Pharmacodynamic Effects

This synthetic peptide mimics the action of GLP-1 at the GLP-1 receptor.

Clinical Trials
Clinical Trial ID	Title	Type	Source	Comment	References
NCT02963766	A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes	Phase 3 Interventional	Eli Lilly and Company		1